Main > A1. CORP. INDEX. M-Mm > Merck & Co Inc./P C2
This data is not available for free
Merck & Co Inc./P C2's subsections
1998. 11.17.1998. (Blood Coag.)
1999. 12.20.1999. (Pediatrics)
2000. 05.15.2000. (Drug Deliv.)
2000. 05.29.2000. (AntiFlea Compd.)
2000. 07.10.2000. (AD/Enzyme)
2000. 10.09.2000. (Comments)
2000. 10.09.2000. (Executive)
2000. 11.27.2000. (Comments)
2001. 01.12.2001. (Executive)
2001. 04.23.2001. (Diabetes)
2001. 05.21.2001. (AIDS)
2001. 05.21.2001. (Parent of)
2001. 09.03.2001. (Asymmetric H)
2001. 12.10.2001. (Evotec OAI)
2002. 05.27.2002. (Process Chem.)
2002. 06.10.2002. (Collaboration)
2002. 06.10.2002. (Pneumology)
2002. 06.17.2002. (AMRI)
2002. 06.17.2002. (Pneumology)
2002. 07.15.2002. (Genomics)
2002. 07.17.2002. (Blood Coag.)
2002. 09.02.2002. (Customer of)
2002. 09.16.2002. (AIDS)
2002. 09.23.2002. (Statins)
2002. 10.14.2002. (Subscriber of)
2002. 11.18.2002. (Supplier)
2002. 11.21.2002. (Oncology)
2002. 12.02.2002. (Fut Blockbuster)
2002. 12.02.2002. (Statin Sales)
2003. 01.13.2003. (Parent of)
2003. 01.17.2003. (Chiral Catalyst)
2003. 02.24.2003. (AD/Sunesis)
2003. 03.17.2003. (AIDS)
2003. 03.17.2003. (Cardiology)
2003. 04.28.2003. (Medco Spin Off)
2003. 05.05.2003. (SARS)
2003. 09.09.2003. (RNAi Alliance)
2003. 10.13.2003. (AntiFungal)
2003. 10.13.2003. (Executive)
2003. 10.16.2003. (Fullerenes)
2003. 10.27.2003. (Oncology)
2003. 11.17.2003. (Oncology)
2003. 11.24.2003. (Physiology)
2003. 12.01.2003. (Neurogen Deal)
2004. 02.16.2004. (Insomnia)
2004. 02.26.2004. (DeCode G. Deal)
2004. 07.27.2004. (Sunesis/Viral..)
2004. 07.28.2004. (AD/Celera Diag)
2004. 08.09.2004. (Onco./Pierre F.)
2004. 09.06.2004. (RNAi/Alnylam)
2004. 09.06.2004. (Suzuki Coupling)
2004. 09.13.2004. (Diabetes)
2004. 09.27.2004. (Obesity)
2004. 10.21.2004. (Asthme/Amrad)
2004. 11.22.2004. (Onco/Rigel..)
2004. 12.13.2004. (ChemBridge Deal)
2005. 05.26.2005. (HoxFollow Tech.)
2005. 05.30.2005. (BioXell Deal)
2005. 05.30.2005. (COX-2 Inhibitor)
2005. 05.30.2005. (Symyx Tech.)
2005. 06.27.2005. (Green 05 Award)
2005. 09.05.2005.(Antrax Inhibitor)
2005. 09.05.2005.(SFC)
2005. 11.28.2005. (Diabetes)
2005. 11.28.2005. (Neuro.>AD)
2006. 03.13.2006. (2-ArPyrrolidone)
2006. 11.10.2006. (COX-2 Inhibitor)
2007. 01.08.2007. Exec. Director
2007. 04.19.2007. (Migraine)
2007. 06.25.2007. (CEO)
2007. 06.25.2007. (Pres. Mfg. Div.)
2007. 08.06.2007. Assoc. Director
2007. 08.06.2007. Sr Director Proc.
2007. 08.13.2007. Exec Director
2007. 09.11.2007. Cardio.>Corp Acq
2007. 09.24.2007. (Harvard)
2007. 10.01.2007. (AIDS Vaccine)
2007. 10.01.2007. (Director Medici)
2007. 10.05.2007. (AntiFungal)
2007. 11.20.2007. (Onco.)
2007. 11.26.2007. (Onco.>R&D>IN)
2007. 11.26.2007. (Sr VP Worldwide)
2007. 12.01.2007. (IE)
2007. 12.03.2007. (Oncology)
2007. 12.03.2007. (Parkinsons D.)
2007. 12.03.2007. (Vaccines>IE)
2008. 01.11.2008. (Osteoporosis)
2008. 01.29.2008. (Oncology)
2008. 02.25.2008. (Shasun)
2008. 03.19.2008. (Onco.)
2008. 03.31.2008. (Obesity)
2008. 04.01.2008. (Cardio.)
2008. 04.14.2008. (Antibiotics)
2008. 04.14.2008. (Osteoporosis)
2008. 04.17.2008. (Hepatology)
2008. 04.24.2008. (Diabetes)
2008. 04.28.2008. (Hepatology)
2008. 05.12.2008. Halts Natl Prods
2008. 05.19.2008. Anti-Infectives
2008. 09.08.2008. Basic NeuroScien
2008. 09.22.2008. Director Clinical
2008. 09.22.2008. Exec. Director
2008. 09.22.2008. VP AntiViral
2008. 11.10.2008. Head Of Bone,
2008. 11.10.2008. Licensing & Ext.
2008. 12.15.2008. BioSimila>MK-2578
2009. 02.12.2009. BioSimila>Insmed
2009. 02.16.2009. BioSimila>Sr VP
2009. 03.16.2009. Proc. Research
2009. 04.21.2009. Infect. Diarrhea
2009. 04.27.2009. Migraine
2009. 04.27.2009. Sarcopenia
2009. 06.01.2009. Onco.>AstraZ.
2009. 06.22.2009. Drugs For Neglect
2009. 07.20.2009. VP Bioprocess
2010. 03.15.2010. Blood Coag.
2010. 06.21.2010. Pres. Green Award
2010. 06.24.2010. Adcock Ingram
2010. 07.08.2010. Integration R&D
2010. 07.27.2010. Sinopharm
2010. 11.20.2010. CV..>HyperChol ES
2010. 12.14.2010. Malaria Vacc.
2011. 01.19.2011. Blood Coag.
2011. 04.11.2011. Onco.>PI3K Inh.
2011. 04.11.2011. Sun Pharma.
2011. 05.01.2011. Ophthalmo.
2011. 05.16.2011. Corp. Acq.
2011. 06.13.2011. RA
2011. 07.11.2011. AIDS UNC & UCSF
2011. 07.18.2011. Hepato.>HCV Boc
2011. 07.21.2011. Simcere Pharma.
2011. 08.29.2011. Zymeworks Inc.
2011. 09.13.2011. BGI
2011. 10.07.2011. Diabetes
2011. 11.10.2011. Pipeline Prog.
2011. 12.12.2011. R&D Center CN
2012. 02.02.2012. Diabetes
2012. 02.08.2012. BoD
2012. 02.13.2012. Ophthalmo.
2012. 02.15.2012. Supera Farma
2012. 03.05.2012. Allergy
2012. 03.15.2012. CALIBR
2012. 03.26.2012. Merck Lumira Bio
2012. 03.28.2012. Chief Ethics &
2012. 04.02.2012. Shingles Vaccine
2012. 04.19.2012. Hepato>HCV>Anemia
2012. 04.27.2012. Patent
2012. 06.14.2012. USA & NO Gov.
2012. 06.15.2012. Patent Litigation
2012. 06.27.2012. AstraZeneca
2012. 07.11.2012. Gates Foundation
2012. 08.26.2012. CV>Blood Coag.
2012. 08.26.2012. CV>CETP Inh.
2012. 10.03.2012. Diabetes
2012. 10.09.2012. Global HQ.
2012. 10.13.2012. Osteoporosis
2012. 10.16.2012. Theravance
2012. 10.23.2012. Gyneco.>Fertility
2012. 11.08.2012. Neuro.>Insomnia
2012. 11.08.2012. Regenstrief Inst.
2012. 11.10.2012. Hepato>HCV
2012. 11.29.2012. Onco.>Sarcoma
2013. 01.25.2013. Uro.>OAB>Women
2013. 02.20.2013. BioSimilars
2013. 03.09.2013. CV>Niacin...
2013. 04.16.2013. CN>Hangzhou>Mfg.
2013. 04.29. Diab>Ertugliflozin
2013. 05.03. CV..>HyperChol>E+A
2013. 05.15. $6.5 B Debt Offer
2013. 05.23. Neuro.>PD
2013. 09.23. Anesthesia
2013. 11.18. Onco.>Melanoma>L
2013. 11.26. AntiFungal>PosaconAzol
2013. 12.10. Neuro.>AD
2013. 12.18. Onco.>Renal C.>GSK
2013. 12.20. New Bus.: Weight Man.
2014. 01.08. AIDS>Raltegravir
2014. 02.05. Onco.>MK-3475
2014. 02.10. Diab>Insulin Glargine
2014. 02.17. Vet.>Dogs>Fleas&Ticks
2014. 02.20. 9-Valent HPV Vaccine
2014. 03.04. Allergy>Dust Mite
2014. 03.05. Hepato>HCV MK-5172+
2014. 03.27. CFO
2014. 04.04. Gyneco.>PPH
2014. 04.14. Allergy>Timothy Grass
2014. 04.17. Allergy>Ragweed
2014. 04.21. USA Gov.>NASA
2014. 05.12. CV.>Vorapaxar
2014. 05.13. Ophthalmo.>Santen
2014. 05.19. Onco.>Ovarian C.
2014. 06.01. Onco.>Head & Neck C.
2014. 06.23. Neuro.>AD>BioNomics
2014. 08.13. Neuro.>Insomnia
2014. 08.26. Onco.>NSCLC>Pfizer (C)
2014. 09.17. TildrakizuMAb
2014. 11.03. AIDS>Doravirine
2014. 11.24. Ebola Vaccine
2014. 12.11. Onco.>HPV Vaccine
2014. 12.18. Acq. OncoEthix
2015. 01.21. Acq. Cubist Completed
2015. 02.23. NGM Biopharmaceuticals
2015. 04.20. PeptiDream Inc
2015. 07.22. Onco.>Melanoma>P
2015. 07.28. Acq. cCAM Bio
2015. 09.02. Onco.>Chemo.>CINV
2015. 09.08. Rheuma.>RA>BioSimilar
2015. 09.28. Diab.>Omarigliptin
2015. 10.02. Onco.>NSCLC
2015. 12.17. Neuro>NMB>Sugammadex
2016. 01.11. Acq. IOmet Pharma
2016. 01.28. Hepato.HCV E+G
2016. 02.04. Onco.>Chemo.>CINV
2016. 03.21. Harvard Uni.
2016. 06.09. Acq. Afferent Pharma
2016. 07.01. AH Acq BR>Vallée SA
2016. 08.02. Onco.>NSCLC
2016. 08.08. Onco.>HNSCC *
2016. 10.21. Infectious Dis.>CDI
2016. 10.24. Onco.>NSCLC
2016. 12.15. Wins $2.5 B. Patent
2017. 01.31. Onco.>NSCLC
2017. 02.14. Neuro.>AD>Verubecestat
2017. 02.16. ILÚM Health Solutions
2017. 05.23. Onco.>Colon>MSI-H
2017. 05.25. Teijin Pharma
2017. 05.30. AIDS
2017. 06.27. CV..>HyperChol>CETP>A
2017. 09.05. Onco.>Bladder C.
2017. 09.06. Acq. Rigontec
2017. 09.22. Onco.>Gastric or GEJ C
2017. 11.09. Infectious Dis.>CMV
2018. 03.07. Onco. Eisai
2018. 05.03. Moderna
2019. 01.03. NASH & Type-2 Diabetes
2019. 05.21. Acq. Peloton Therapeut
2019. 06.03. Pneumo.>HABP/VABP
2019. 06.10. Acq.Tilos Therapeutics
2019. 06.11. Onco.>HNSCC USA>OK *
2019. 06.18. Onco.>SCLC *
2019. 07.17. Infectious Dis..>cUTI
2019. 07.31. Onco.>Esophageal C.
2019. 09.04. Onco.>RCC>EU>OK
2019. 09.20. AIDS>HIV-1
2019. 11.11. Ebola Zaire Vac. EU>OK
2019. 11.20. Onco.>HNSCC EU>OK *
2019. 11.26. Onco.>NSCLC>CN>OK
2019. 12.09. Acq. Arqule
2019. 12.09. Acq. Arqule
2019. 12.20. Ebola Zaire Vac. US>OK
2019. 12.20. Onco.>Pembro ..>JP>OK
2020. 01.08. Onco.>Bladder C.
2020. 01.27. Infect.>CDAD>Children
2020. 05.26. Acq. Themis
2020. 06.05. Infectious.>HABP/VABP
2020. 06.12. Onco.>Head & Neck C.
2020. 06.17. Debt Offering
2020. 06.17. Onco.>Solid Tumors
2020. 06.19. Acq. Themis
2020. 06.22. Onco.>ESCC>CN>OK
2020. 06.24. Onco.>cSCC>USA>OK
2020. 06.29. Onco.>Colon C.>USA>OK
2020. 08.24. Onco.>ESCC>JP>OK
2020. 09.14. Onco.>Seattle Genetics
2020. 09.24. Gyne.>Contraceptive
2020. 10.15. Onco.>cHL>USA>OK
2020. 10.15. Onco.>HNSCC>CA>OK
2020. 11.05. Acq. VelosBio
2020. 11.23. Acq. OncoImmune
2021. 01.20. Cardio.>Vericiguat>USA
2021. 01.25. COVID-19>Molnupiravir
2021. 01.26. Onco.>Colon C.>EU>OK
2021. 02.25. Acq. Pandion Therapeut
2021. 04.01. Acq. Pandion Therapeut
2021. 06.01. 6 in 1 Pediatric Vacc.
2021. 07.06. Onco.>cSCC
2021. 07.16. Pneumococcal Disease
2021. 07.21. Cardio.>Vericiguat>EU
2021. 07.22. Onco.>Endometrial C.
2021. 08.13. Onco.>VHL Dis.-A
2021. 09.30. Acq. Acceleron Pharma
2021. 10.11. COVID-19
2021. 10.13. Onco.>Cervical C.
2021. 11.04. COVID-19>UK>OK
2021. 11.22. Acq. Acceleron Pharma
2022. 03.21. Onco.>Endometrial C.
2022. 04.18. Onco.>TNBC>CA>OK
2022. 04.29. Onco.>5 Cancers>EU>OK
2022. 04.29. Onco.>Cervical C>EU>OK
2022. 05.24. Onco.>Breast C.>EU>OK
2022. 06.22. Vaccine>USA>OK
2022. 06.24. Onco.>Melanoma>EU>OK
2022. 09.13. Onco.>Melanoma>CA>OK
2022. 09.27. Onco.>TNBC>JP>OK
2022. 10.22. Onco.>RCC>CA>OK
2022. 11.21. Acq. Imago Bio
2022. 12.22. CN>Kelun-Biotech./P
2023. 01.27. Onco.>Lung C.>USA>OK
2023. 03.06. US FDA Approves
2023. 04.03. US FDA Approves
2023. 04.16. Acq. Prometheus Biosci
2023. 06.06. USA FDA Approval
2023. 08.03. USA FDA Approval
2023. 11.01. Onco.>BTC>USA>OK
2023. 11.16. Onco.>Gastric/GEJ>USA>
2023. 11.21. Acq. Caraway Therapeut
2023. 12.14. Onco.>RCC>USA>OK
2023. 12.18. EU>EC Approval
2024. 01.08. Acq. Harpoon Therapeut
2024. 03.26. Cardio.>PAH>USA>OK
2024. 08.06. Daiichi Sankyo
2024. 08.09. Curon Biopharmaceutica
2024. 11.14. LaNova Medicines Ltd
Merck Animal Health. C2
Merck Frosst Canada/P C2
Merck Research Laboratories C2
Merck Sharp & Dohme/P C2
Patents
Web-Site
Z - OK
Merck & Co Inc./P C2's products
This section has no products